Pieris Pharmaceuticals Total Non-Operating Income/Expense 2014-2024 | PVLA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pieris Pharmaceuticals total non-operating income/expense from 2014 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.

Pieris Pharmaceuticals Total Non-Operating Income/Expense 2014-2024 | PVLA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pieris Pharmaceuticals total non-operating income/expense from 2014 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
NPK (NPKI)	$626M
Performant Healthcare (PHLT)	$245M
FTAC Emerald Acquisition (FLDD)	$158M
Swiftmerge Acquisition (ANNA)	$42M
Insight Acquisition (AMOD)	$23M
Hanryu Holdings (GITS)	$17M
LQR House (YHC)	$11M
ATIF Holdings (ZBAI)	$9M
Lion Electric (LEVGQ)	$0M